$SNPS

Synopsys is becoming a major AI player: CEO discusses OpenAI, Amazon deals

Synopsys CEO discusses partnerships with OpenAI and Amazon. The OpenAI deal aims to enhance AI capabilities for chip design, while the Amazon agreement involves a $1 billion commitment for Synopsys' application-optimized IP to build custom AI chips. The company expects more large customers in this emerging market.

Original reporting
Published Oct 1, 2026, 8:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys is becoming a major AI player: CEO discusses OpenAI, Amazon deals — source image
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The Amazon partnership could accelerate Synopsys' revenue growth and enhance its positioning against rivals like Cadence.

02

Market read

A major AI‑chip IP contract that may boost Synopsys' earnings outlook and influence the broader AI‑hardware supply chain.

03

What to watch

Execution risk on delivering the IP and competition from other EDA vendors could limit upside

Relevance 7/10Novelty 7/10Timing: recently announced

Background

Synopsys is expanding its AI‑focused IP portfolio to serve the growing demand for custom chips from cloud and AI leaders.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys announced a new partnership with Amazon, securing a billion‑dollar commitment for its application‑optimized IP to be used in Amazon's next AI chip.

Expected impact

likely upside as investors price in the large Amazon deal and expanded AI IP business

Evidence & confidence

A billion‑dollar deal with a marquee customer is a material, first‑report contract that can materially lift Synopsys' top‑line and sentiment.

Market effects

strengthens the custom silicon and AI‑chip design ecosystem, benefiting EDA and IP providers

U.S. tech sector gains from increased AI‑chip spending

signals broader industry shift toward in‑house AI chip development

Counterpoint

If the Amazon deal is smaller than implied or delayed, the impact on Synopsys could be muted

Key entities

  • Synopsys

    U.S. EDA and IP provider (ticker SNPS)

  • Amazon

    Lead customer committing to use Synopsys' application‑optimized IP

Related articles

$SNPSHighAI 8/10

Synopsys Stock Jumps As AI Deals And Guidance Ignite Bulls

Synopsys Inc. (NASDAQ: SNPS) stock rose 12.77% on October 1, 2026, driven by strong AI chip-design demand and bullish investor sentiment. The company's stock has increased from $392 to $490.54 in a few weeks. Synopsys reported strong financials, including a P/E of 72.7, price-to-sales of 8.45, and revenue growth above 20% over three years. The company guided FY27 revenue at $11.15B and adjusted EPS at $19.04–$19.12, exceeding consensus estimates.

$SNPSHighAI 9/10

Synopsys Stock Jumps As AI Deals And Guidance Heat Up

Synopsys Inc. (NASDAQ: SNPS) stock rose 12.77% on October 1, 2026, driven by AI-driven chip design leadership and strong guidance. The company expects FY27 revenue of $11.1-11.2B, up from prior estimates of $10.8B, and adjusted EPS of $19.04-19.12. Synopsys also announced AI deals with OpenAI and Amazon, boosting its growth outlook.

$SNPSHighAI 8/10

Synopsys Stock Jumps As AI Deals And Guidance Ignite Bull Run

Synopsys Inc. (NASDAQ: SNPS) stock rose 12.81% on October 1, 2026, driven by strong AI-chip design demand and bullish investor sentiment. The company reported revenue of $7.05B, gross margins of 72.4%, and EBITDA margins of 32.2%. Key catalysts include a multi-year $1B+ deal with Amazon and a partnership with OpenAI. Synopsys guided to 15% revenue growth for FY27, with non-GAAP operating margins around 44%. HSBC upgraded SNPS to Buy with a price target of $700.

$SNPSHigh

Synopsys Stock Rises 9%

Synopsys (SNPS) stock rose 9.38% to $475.74 on Thursday, following a strategic partnership with OpenAI to develop GPT-Synopsys, an AI model for semiconductor design. The company's stock traded between $462.00 and $493.30 with higher-than-average volume. The 52-week range is $362.55 to $539.48.

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.